Commercializing Innovation in China’s Multi-Layered Coverage Framework
A High-Density Executive Alignment Engagement for Global and China Leadership
China’s pharmaceutical payment system is no longer a single-channel problem. As basic medical insurance and commercial health insurance increasingly intersect, access decisions have become system-level, path-dependent, and portfolio-shaping.
This two-session executive engagement compresses the structural logic of China’s evolving multi-layer coverage framework into a focused leadership discussion—clarifying how pricing, pathway choice, and pull-through risks interact across payment layers to shape both long-term flexibility and near-term adoption.
Not a training session.
Not a generic market overview.
Not a slide-heavy workshop.
This is a structured executive alignment engagement designed to replace fragmented internal debate with clarity on the trade-offs that truly matter.
What Leadership Gains
In two concentrated discussions, global and China leadership teams:
- Align on the structural forces reshaping pricing and reimbursement in China
- Clarify cross-layer trade-offs and their implications for pricing integrity and adoption dynamics
- Distinguish structural system constraints from genuine strategic flexibility
- Surface competitive and organizational pressures shaping critical access decisions
- Identify risks that require explicit executive alignment before pathway commitment
The outcome is compressed clarity—often replacing weeks of internal back-and-forth with a shared strategic lens.
Format
Two 60-minute virtual sessions delivered over approximately two weeks.
Session 1 — Strategic Architecture Primer
A high-density executive briefing that establishes a shared decision framework.
Session 2 — Asset-Focused Alignment
A structured discussion anchored in a selected priority asset, clarifying trade-offs and decision thresholds.
Participants receive session materials and a one-month complimentary Access360 trial.
Why This Engagement Is Different
This engagement integrates:
- Policy architecture
- Cross-layer pricing dynamics
- Pull-through risk analysis
- Competitive dynamics
- Organizational incentive alignment
It is designed for leadership teams navigating real asset-level decisions under uncertainty—where early choices carry long-term implications.
Program Leadership
This engagement is designed and led by Kelly Ke, founder of bizi LLC and architect of NRDL+. Operating at the intersection of health policy and executive decision-making, she helps life sciences leadership teams navigate China’s evolving multi-layer coverage architecture with structured strategic clarity.
A former award-winning Deloitte U.S. life sciences advisor and co-author of the widely discussed Caixin analysis on the C-List roadmap, Kelly brings system-level insight and disciplined decision framing to complex access decisions.
Turn complexity into clarity.
Turn policy shifts into strategic foresight.